Literature DB >> 21057373

Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome.

Maaike A Kusters1, C M Jol-van der Zijde, Maarten J van Tol, W E Bolz, L A Bok, Marjan Visser, Esther de Vries.   

Abstract

Down syndrome children show a decreased avidity of the antibody response after tetanus toxoid booster vaccination at 9 years of age suggesting impaired memory B cell selection in the germinal center. Clinicians need to be aware of this ongoing subtle immunologic deficit in Down syndrome.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21057373     DOI： 10.1097/INF.0b013e3181ff85a8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Altered endotoxin responsiveness in healthy children with Down syndrome.

Authors:  Dean Huggard; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Timothy Ronan Leahy; Orla Franklin; Ana Moreno; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  BMC Immunol       Date:  2018-11-03       Impact factor: 3.615

3.  Altered Toll-Like Receptor Signalling in Children with Down Syndrome.

Authors:  Dean Huggard; W J Koay; Lynne Kelly; Fiona McGrane; Emer Ryan; Niamh Lagan; Edna Roche; Joanne Balfe; T Ronan Leahy; Orla Franklin; Ana Moreno-Oliveira; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  Mediators Inflamm       Date:  2019-09-12       Impact factor: 4.711

4.  Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center.

Authors:  Aurélien Guffroy; Yannick Dieudonné; Beatrice Uring-Lambert; Joelle Goetz; Yves Alembik; Anne-Sophie Korganow
Journal:  Orphanet J Rare Dis       Date:  2019-01-11       Impact factor: 4.123

Review 5.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

6.  Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.

Authors:  Diletta Valentini; Nicola Cotugno; Vittorio Scoppola; Chiara Di Camillo; Luna Colagrossi; Emma Concetta Manno; Carlo Federico Perno; Cristina Russo; Paolo Palma; Paolo Rossi; Alberto Villani
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

7.  Melatonin as an immunomodulator in children with Down syndrome.

Authors:  Dean Huggard; Lynne Kelly; Amy Worrall; Eleanor Gallagher; Lida Fallah; Lucas Lu Yoo; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Derek G Doherty; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2021-08-16       Impact factor: 3.953

Review 8.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  Altered expression of immune-related genes in children with Down syndrome.

Authors:  Bruna Lancia Zampieri; Joice Matos Biselli-Périco; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Wilson Araújo Silva Júnior; Eny Maria Goloni-Bertollo; Erika Cristina Pavarino
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.